116 related articles for article (PubMed ID: 10626791)
1. Growth suppression of human ovarian cancer cells by adenovirus-mediated transfer of the PTEN gene.
Minaguchi T; Mori T; Kanamori Y; Matsushima M; Yoshikawa H; Taketani Y; Nakamura Y
Cancer Res; 1999 Dec; 59(24):6063-7. PubMed ID: 10626791
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus-mediated transfer of the PTEN gene inhibits human colorectal cancer growth in vitro and in vivo.
Saito Y; Swanson X; Mhashilkar AM; Oida Y; Schrock R; Branch CD; Chada S; Zumstein L; Ramesh R
Gene Ther; 2003 Nov; 10(23):1961-9. PubMed ID: 14528320
[TBL] [Abstract][Full Text] [Related]
3. Adenoviral transduction efficiency of ovarian cancer cells can be limited by loss of integrin beta3 subunit expression and increased by reconstitution of integrin alphavbeta3.
Brüning A; Köhler T; Quist S; Wang-Gohrke S; Moebus VJ; Kreienberg R; Runnebaum IB
Hum Gene Ther; 2001 Mar; 12(4):391-9. PubMed ID: 11242531
[TBL] [Abstract][Full Text] [Related]
4. The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells.
Lu Y; Lin YZ; LaPushin R; Cuevas B; Fang X; Yu SX; Davies MA; Khan H; Furui T; Mao M; Zinner R; Hung MC; Steck P; Siminovitch K; Mills GB
Oncogene; 1999 Nov; 18(50):7034-45. PubMed ID: 10597304
[TBL] [Abstract][Full Text] [Related]
5. The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene.
Li J; Simpson L; Takahashi M; Miliaresis C; Myers MP; Tonks N; Parsons R
Cancer Res; 1998 Dec; 58(24):5667-72. PubMed ID: 9865719
[TBL] [Abstract][Full Text] [Related]
6. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death.
Weng LP; Smith WM; Dahia PL; Ziebold U; Gil E; Lees JA; Eng C
Cancer Res; 1999 Nov; 59(22):5808-14. PubMed ID: 10582703
[TBL] [Abstract][Full Text] [Related]
7. Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer.
Cheney IW; Johnson DE; Vaillancourt MT; Avanzini J; Morimoto A; Demers GW; Wills KN; Shabram PW; Bolen JB; Tavtigian SV; Bookstein R
Cancer Res; 1998 Jun; 58(11):2331-4. PubMed ID: 9622068
[TBL] [Abstract][Full Text] [Related]
8. Suppression of gastric cancer growth by adenovirus-mediated transfer of the PTEN gene.
Hang Y; Zheng YC; Cao Y; Li QS; Sui YJ
World J Gastroenterol; 2005 Apr; 11(15):2224-9. PubMed ID: 15818730
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus-mediated intraarterial delivery of PTEN inhibits neointimal hyperplasia.
Huang J; Niu XL; Pippen AM; Annex BH; Kontos CD
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):354-8. PubMed ID: 15569824
[TBL] [Abstract][Full Text] [Related]
10. Enhanced cell growth inhibition following PTEN nonviral gene transfer using polyethylenimine and photochemical internalization in endometrial cancer cells.
Maurice-Duelli A; Ndoye A; Bouali S; Leroux A; Merlin JL
Technol Cancer Res Treat; 2004 Oct; 3(5):459-65. PubMed ID: 15453811
[TBL] [Abstract][Full Text] [Related]
11. The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells.
Furnari FB; Huang HJ; Cavenee WK
Cancer Res; 1998 Nov; 58(22):5002-8. PubMed ID: 9823298
[TBL] [Abstract][Full Text] [Related]
12. Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway.
Unoki M; Nakamura Y
Oncogene; 2001 Jul; 20(33):4457-65. PubMed ID: 11494141
[TBL] [Abstract][Full Text] [Related]
13. PTEN gene therapy induces growth inhibition and increases efficacy of chemotherapy in prostate cancer.
Tanaka M; Rosser CJ; Grossman HB
Cancer Detect Prev; 2005; 29(2):170-4. PubMed ID: 15829377
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated gene transfer of MMAC1/PTEN to glioblastoma cells inhibits S phase entry by the recruitment of p27Kip1 into cyclin E/CDK2 complexes.
Cheney IW; Neuteboom ST; Vaillancourt MT; Ramachandra M; Bookstein R
Cancer Res; 1999 May; 59(10):2318-23. PubMed ID: 10344736
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of PTEN increases sensitivity to SN-38, an active metabolite of the topoisomerase I inhibitor irinotecan, in ovarian cancer cells.
Saga Y; Mizukami H; Suzuki M; Kohno T; Urabe M; Ozawa K; Sato I
Clin Cancer Res; 2002 May; 8(5):1248-52. PubMed ID: 12006545
[TBL] [Abstract][Full Text] [Related]
16. PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein.
Paramio JM; Navarro M; Segrelles C; Gómez-Casero E; Jorcano JL
Oncogene; 1999 Dec; 18(52):7462-8. PubMed ID: 10602505
[TBL] [Abstract][Full Text] [Related]
17. Adenoviral-mediated PTEN transgene expression sensitizes Bcl-2-expressing prostate cancer cells to radiation.
Rosser CJ; Tanaka M; Pisters LL; Tanaka N; Levy LB; Hoover DC; Grossman HB; McDonnell TJ; Kuban DA; Meyn RE
Cancer Gene Ther; 2004 Apr; 11(4):273-9. PubMed ID: 14765130
[TBL] [Abstract][Full Text] [Related]
18. PTEN sensitizes prostate cancer cells to death receptor-mediated and drug-induced apoptosis through a FADD-dependent pathway.
Yuan XJ; Whang YE
Oncogene; 2002 Jan; 21(2):319-27. PubMed ID: 11803475
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus-mediated delivery of the PTEN gene inhibits cell growth by induction of apoptosis in endometrial cancer.
Sakurada A; Hamada H; Fukushige S; Yokoyama T; Yoshinaga K; Furukawa T; Sato S; Yajima A; Sato M; Fujimura S; Horii A
Int J Oncol; 1999 Dec; 15(6):1069-74. PubMed ID: 10568810
[TBL] [Abstract][Full Text] [Related]
20. PI3 kinase blockade by Ad-PTEN inhibits invasion and induces apoptosis in RGP and metastatic melanoma cells.
Stewart AL; Mhashilkar AM; Yang XH; Ekmekcioglu S; Saito Y; Sieger K; Schrock R; Onishi E; Swanson X; Mumm JB; Zumstein L; Watson GJ; Snary D; Roth JA; Grimm EA; Ramesh R; Chada S
Mol Med; 2002 Aug; 8(8):451-61. PubMed ID: 12435856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
